Other News

Inari Medical Announces Completion of Patient Enrollment in the FLARE Study for the Treatment of Pulmonary Embolism

IRVINE, Calif., Oct. 24, 2017 /PRNewswire/ — Inari Medical, Inc., a privately held venture backed medical device company dedicated to the development of innovative catheter-based technologies for the treatment of venous thromboembolism (“VTE”), announced today it has completed enrollment of its Investigational Device Exemption (“IDE”) study. The FlowTriever Pulmonary Embolectomy Clinical Study (“FLARE”) […]

BioSig Technologies Adds Role of Manufacturing Project Leader as Company Continues to Advance Towards Commercialization

Minneapolis, MN, Oct. 24, 2017 (GLOBE NEWSWIRE) — BioSig Technologies(OTCQB: BSGM), a medical device company developing a proprietary platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has engaged Quintain Project Solutions LLC as the manufacturing project management leader for […]

Coming soon: Spotlight on image-guided patient care at SIR 2018

FAIRFAX, Va., Oct. 23, 2017 /PRNewswire-USNewswire/ — Online registration is open for the Society of Interventional Radiology (SIR) 2018 Annual Scientific Meeting. The meeting takes place March 17–22, 2018, at the Los AngelesConvention Center in Los Angeles, Calif. SIR 2018 brings together more than 5,000 interventional radiology physicians, fellows, trainees and related health care professionals to explore […]

Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil® Drug-Coated Balloon

EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced enrollment of the first patient in TRANSCEND, the pivotal clinical trial for the SurVeil® drug-coated balloon (DCB). The randomized trial will evaluate the SurVeil DCB for treatment for peripheral artery disease (PAD) in […]

Abbott Launches the First and Only Smartphone Compatible Insertable Cardiac Monitor in the U.S.

ABBOTT PARK, Ill., Oct. 23, 2017 /PRNewswire/ — Abbott (NYSE: ABT) has secured U.S. Food and Drug Administration (FDA) clearance for the Confirm Rx™ Insertable Cardiac Monitor (ICM), the world’s first and only smartphone compatible ICM designed to help physicians remotely identify cardiac arrhythmias. With FDA clearance Abbott can now provide U.S. patients a new […]

Micro Interventional Devices Continues Clinical Success of MIA Technology

NEWTOWN, Pa., Oct. 23, 2017 /PRNewswire/ — Micro Interventional Devices, Inc. announced today the second successful implantation of its MIA (Minimally Invasive Annuloplasty) technology. The patient was enrolled in the first arm of the STTAR (Study of Transcatheter Tricuspid Annular Repair) clinical trial studying the safety and efficacy of MID’s MIA device […]

First Patient Treated in Medtronic’s Landmark Transcatheter Mitral Valve Replacement (TMVR) Pivotal Trial

DUBLIN – October 23, 2017 – Medtronic (NYSE:MDT) today announced the first patient implant in the APOLLO Trial – the pivotal trial designed to evaluate the Intrepid(TM) TMVR system following receipt of an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA). As the first-ever pivotal trial for transcatheter […]

Corindus Evaluates Incorporating HeartFlow Technology with CorPath GRX System

WALTHAM, Mass.–(BUSINESS WIRE)– Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that it will incorporate the HeartFlow® FFRct Analysis in a case series of robotic-assisted percutaneous coronary intervention (PCI) procedures with the CorPath® GRX System to evaluate the feasibility and utility of clinical decision support. “We are […]

Bay Area’s Claret Medical Nabs $14.5M

SANTA ROSA, Calif.–(BUSINESS WIRE)– Claret Medical, developer of the Sentinel® Cerebral Protection System, the first FDA-cleared cerebral protection device for transcatheter aortic valve replacement (TAVR), today announced that it has closed on a Series C financing of $14.5 million led by Lightstone Ventures, with participation from existing investors Easton Capital, HealthCor Partners, […]